| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.1B | $2.0B | $2.1B | $2.0B | $1.9B | $1.8B | — |
| Cost of Revenue | $4.9B | $4.9B | $4.7B | $4.1B | $4.1B | $4.2B | $4.0B | — |
| Gross Profit | $1.1B | $1.0B | $1.0B | $1.1B | $1.0B | $0.9B | $0.9B | $0.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.9B | $1.8B | $1.9B | $1.7B | $1.7B | $1.6B | $1.7B | $1.4B |
| Operating Income | $0.4B | $3.2B | $2.8B | $2.3B | $2.8B | $2.2B | $2.4B | $2.4B |
| Net Income | $-0.4B | $0.4B | $0.2B | $0.4B | $0.4B | $0.4B | $1.2B | $0.5B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.7B | $25.7B | $24.7B | $25.9B | $27.1B | $27.3B | $29.2B | $18.6B |
| Current Assets | $3.7B | $3.7B | $3.5B | $3.3B | $3.0B | $3.5B | $3.7B | $3.2B |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $0.2B | $0.5B | $0.1B | $0.1B | $0.2B |
| Total Liabilities | $14.5B | $15.6B | $15.9B | $13.8B | $13.2B | $14.8B | $16.4B | $11.7B |
| Current Liabilities | $4.0B | $3.1B | $3.0B | $2.7B | $1.3B | $2.3B | $3.2B | $2.7B |
| Stockholders' Equity | $6.9B | $9.7B | $8.4B | $11.7B | $13.6B | $12.1B | $12.6B | $6.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2018↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.2B | $2.8B | $2.8B | $2.7B | $2.8B | $2.6B | — | — |
| Investing Cash Flow | $-1.0B | $-1.3B | $-1.0B | $-1.0B | $-0.1B | $-0.5B | — | — |
| Capital Expenditures | $1.2B | $1.3B | $1.0B | $1.0B | $0.9B | $0.7B | $0.9B | $0.9B |
| Financing Cash Flow | $-2.3B | $-1.5B | $-1.8B | $-1.9B | $-2.3B | $-2.0B | — | — |